Max Healthcare

Why is Max Healthcare Institute Ltd falling/rising?

As of 28-Aug, Max Healthcare Institute Ltd's stock price is rising to 1,013.05, reflecting increased investor confidence and participation. Strong financial health, evidenced by a low Debt to EBITDA ratio and significant long-term growth, supports this upward trend despite some negative factors.

As of 28-Aug, Max Healthcare Institute Ltd's stock price is rising, currently at 1,013.05, with a change of 5.05 (0.5%) upward. This increase follows a trend reversal after two consecutive days of decline. The stock has shown a performance today that is inline with its sector, indicating a positive shift in investor sentiment.<BR><BR>Several factors contribute to this rise. Notably, there has been a rising investor participation, with a delivery volume of 9.75 lacs on 27 August, which is an increase of 5.79% compared to the 5-day average delivery volume. This suggests that more investors are willing to hold the stock, reflecting confidence in its future performance.<BR><BR>Additionally, the company demonstrates strong financial health, evidenced by a low Debt to EBITDA ratio of 1.55 times, indicating a solid ability to service its debt. The company has also experienced healthy long-term growth, with net sales growing at an annual rate of 21.81% and operating profit at 32.41%. High institutional holdings at 71.73% further support the stock's stability, as institutional investors typically have more resources to analyze the fundamentals of companies.<BR><BR>Despite some negative factors, such as a decline in profit after tax and a high valuation relative to its return on capital employed, the recent positive performance and investor confidence have contributed to the stock's upward movement. Overall, the combination of improved investor participation and strong financial metrics is driving the stock price of Max Healthcare Institute Ltd higher.

Which are the latest news on Max Healthcare?

Should I buy, sell or hold Max Healthcare Institute Ltd?

Who are in the management team of Max Healthcare?

The management team of Max Healthcare includes Chairman Abhay Soi, along with several independent and non-executive directors, such as Anil Bhatnagar, K Narasimha Murthy, and Mahendra Lodha, among others, who oversee the company's strategic direction and governance.

The management team of Max Healthcare includes the following individuals:<BR><BR>1. **Abhay Soi** - Chairman / Executive Director<BR>2. **Anil Bhatnagar** - Non-Executive & Non-Independent Director<BR>3. **K Narasimha Murthy** - Independent Non-Executive Director<BR>4. **Mahendra Lodha** - Independent Non-Executive Director<BR>5. **Michael Thomas Neeb** - Independent Non-Executive Director<BR>6. **Pranav Amin** - Independent Non-Executive Director<BR>7. **Amrita Gangotra** - Independent Non-Executive Director<BR>8. **Narayan Seshadri** - Non-Executive Director<BR><BR>This team is responsible for overseeing the strategic direction and governance of the company. If you have any more questions about Max Healthcare or its operations, feel free to ask!

What does Max Healthcare do?

Max Healthcare Institute Ltd is a mid-cap company in the hospital industry, reporting net sales of ₹2,366 Cr and a net profit of ₹323 Cr for June 2026, with a market cap of ₹98,677 Cr. Key metrics include a P/E ratio of 66.00 and a dividend yield of 0.20%.

Overview:<BR>Max Healthcare Institute Ltd operates in the hospital industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was originally incorporated as "Infinitum Technologies Private Limited" in 2001. It changed its name to "Max Healthcare Institute Private Limited" in 2002 and subsequently to "Max Healthcare Institute Limited" later that same year. The latest quarterly results report net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 2,366 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 323 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 98,677 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 66.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.20% <BR>Debt-Equity: 0.26 <BR>Return on Equity: 13.79% <BR>Price to Book: 9.13 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Max Healthcare?

Max Healthcare's peers include Apollo Hospitals, Aster DM Healthcare, Fortis Health, Global Health, Narayana Hrudaya, Krishna Institute, Dr. Agarwal's Healthcare, and Rainbow Children. In terms of performance, Max Healthcare has average management risk and the lowest 1-year return among its peers at -20.39%.

Peers: The peers of Max Healthcare are Apollo Hospitals, Aster DM Quality, Fortis Health., Global Health, Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, and Rainbow Child.<BR><BR>Quality Snapshot: Excellent management risk is observed at Apollo Hospitals, Global Health, Narayana Hrudaya, and Rainbow Child, while Good management risk is found at Aster DM Quality, Fortis Health., Krishna Institu., and Dr Agarwal's Hea. Average management risk is present at Max Healthcare and Fortis Health. Growth is excellent at Apollo Hospitals, Max Healthcare, and Narayana Hrudaya, while Good growth is noted at Fortis Health., Dr Agarwal's Hea, and Global Health. Below Average growth is seen at Aster DM Quality and Krishna Institu., and the rest. Capital Structure is excellent at Max Healthcare and Global Health, while Good capital structure is found at Fortis Health., Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, and Rainbow Child, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aster DM Quality at 34.49%, while Max Healthcare has the lowest at -20.39%. Max Healthcare's return is significantly lower than its peers. Additionally, the peers with negative six-month returns include Max Healthcare, Fortis Health., and Narayana Hrudaya.

How big is Max Healthcare?

As of 14th August, Max Healthcare Institute Ltd has a market capitalization of 98,297.62 Cr, with recent net sales of 8,712.05 Cr and a net profit of 1,457.40 Cr. The company reported shareholder's funds of 10,746.63 Cr and total assets of 17,184.45 Cr for the annual period ending March 2026.

As of 14th August, Max Healthcare Institute Ltd has a market capitalization of 98,297.62 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, Max Healthcare reported Net Sales of 8,712.05 Cr and a Net Profit of 1,457.40 Cr.<BR><BR>For the latest annual period ending in March 2026, the company had Shareholder's Funds amounting to 10,746.63 Cr and Total Assets of 17,184.45 Cr.

Are Max Healthcare Institute Ltd latest results good or bad?

Max Healthcare Institute Ltd's latest results show strong operational performance with a net profit increase and revenue growth, but concerns about stock underperformance, rising interest expenses, and high valuations suggest caution for investors.

Max Healthcare Institute Ltd's latest results present a mixed picture. On the positive side, the company reported a net profit of ₹342.22 crore for Q4 FY26, which is a 13.72% increase quarter-on-quarter (QoQ) and a 7.28% increase year-on-year (YoY). Revenue also saw growth, reaching ₹2,142.89 crore, up 3.65% QoQ and 12.21% YoY. Additionally, the operating margin improved to 28.30%, marking the highest quarterly margin in recent times.<BR><BR>However, there are significant concerns. The company's stock has underperformed compared to its sector peers, declining 11.09% over the past year while the hospital sector gained 19.53%. The rising interest expenses, which surged to ₹66.66 crore, and a high price-to-earnings ratio of 73x raise questions about the sustainability of its premium valuation. Furthermore, the Mojo Score of 42 out of 100 indicates a "SELL" rating, reflecting worries about expensive valuations and flat near-term financial trends.<BR><BR>In summary, while the operational performance shows strength, the financial structure and market sentiment suggest caution for investors.

When is the next results date for Max Healthcare Institute Ltd?

The next results date for Max Healthcare Institute Ltd is 05 February 2026.

The next results date for Max Healthcare Institute Ltd is scheduled for 05 February 2026.

Is Max Healthcare technically bullish or bearish?

As of December 4, 2025, Max Healthcare's trend has shifted to bearish with moderate strength, supported by bearish signals from the MACD, KST, and moving averages, despite some mixed signals on the monthly timeframe.

As of 4 December 2025, the technical trend for Max Healthcare has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the weekly MACD and KST both showing bearish signals, along with daily moving averages confirming a bearish trend. The Bollinger Bands indicate a bearish outlook on the weekly timeframe, while the monthly indicators show a mix of mildly bearish and mildly bullish signals, suggesting some divergence. Overall, the bearish trend is reinforced by the recent price action, with a notable decline in the past week and month compared to the Sensex.

How has been the historical performance of Max Healthcare?

Max Healthcare has experienced substantial growth from Mar'20 to Mar'25, with net sales increasing from 1,059.03 Cr to 7,028.46 Cr, and profit after tax rising from 12.91 Cr to 1,075.88 Cr. Total assets grew from 3,973.66 Cr to 15,186.44 Cr, reflecting the company's successful expansion strategy.

Answer:<BR>Max Healthcare has shown significant growth in its historical performance, particularly in net sales, which increased from 1,059.03 Cr in Mar'20 to 7,028.46 Cr in Mar'25. This upward trend is reflected in total operating income, which also rose from 1,059.03 Cr in Mar'20 to 7,028.46 Cr in Mar'25. The total expenditure, excluding depreciation, grew from 965.45 Cr in Mar'20 to 5,179.66 Cr in Mar'25, indicating increased operational costs alongside revenue growth. Operating profit (PBDIT) has similarly improved, climbing from 141.66 Cr in Mar'20 to 2,004.44 Cr in Mar'25, while profit before tax increased from 12.78 Cr in Mar'20 to 1,406.37 Cr in Mar'25. The profit after tax also saw a rise, reaching 1,075.88 Cr in Mar'25 compared to 12.91 Cr in Mar'20. The company's earnings per share (EPS) increased from 1.1 in Mar'20 to 11.07 in Mar'25, showcasing enhanced profitability per share. On the balance sheet, total assets grew from 3,973.66 Cr in Mar'20 to 15,186.44 Cr in Mar'25, while total liabilities increased from 3,973.66 Cr to 2,488.83 Cr in the same period. Cash flow from operating activities improved significantly, reaching 1,459.00 Cr in Mar'25, although cash flow from investing activities showed a negative trend at -1,614.00 Cr.<BR><BR>Breakdown:<BR>Max Healthcare's financial performance has demonstrated remarkable growth over the years, particularly in net sales, which surged from 1,059.03 Cr in Mar'20 to 7,028.46 Cr in Mar'25. This growth in revenue is accompanied by a corresponding increase in total operating income, which reached 7,028.46 Cr in Mar'25, up from 1,059.03 Cr in Mar'20. The company's total expenditure also rose significantly, from 965.45 Cr in Mar'20 to 5,179.66 Cr in Mar'25, reflecting the costs associated with scaling operations. Operating profit (PBDIT) has shown a strong upward trajectory, increasing from 141.66 Cr in Mar'20 to 2,004.44 Cr in Mar'25, while profit before tax improved from 12.78 Cr to 1,406.37 Cr in the same period. The profit after tax reached 1,075.88 Cr in Mar'25, a substantial increase from 12.91 Cr in Mar'20. The earnings per share (EPS) also rose significantly, indicating improved profitability for shareholders. On the balance sheet, total assets expanded from 3,973.66 Cr to 15,186.44 Cr, while total liabilities increased from 3,973.66 Cr to 2,488.83 Cr, reflecting the company's growth strategy. Additionally, cash flow from operating activities improved to 1,459.00 Cr in Mar'25, despite a negative cash flow from investing activities of -1,614.00 Cr, indicating ongoing investments in growth.

Who are the top shareholders of the Max Healthcare?

The top shareholders of Max Healthcare include Abhay Soi with 23.73%, Foreign Institutional Investors holding 54.74%, and mutual funds with 13.38%. The Government of Singapore is the largest public shareholder at 5.69%, while individual investors own 3.31%, with no pledged promoter holdings.

The top shareholders of Max Healthcare include a mix of institutional and individual investors. The largest shareholder is Abhay Soi, who holds 23.73% of the company. Foreign Institutional Investors (FIIs) are significant shareholders as well, collectively holding 54.74% of the shares, represented by 1020 FIIs. Additionally, mutual funds have a presence with 13.38% held across 33 schemes. The Government of Singapore is the highest public shareholder, owning 5.69%. Individual investors collectively hold 3.31% of the shares. Notably, there are no pledged promoter holdings.

Is Max Healthcare overvalued or undervalued?

As of October 29, 2021, Max Healthcare Institute Ltd. is considered very expensive with a PE ratio of 100.29, significantly higher than its peers, indicating it may be overvalued despite a 43% return over the past year compared to the Sensex's 7.55%.

As of 29 October 2021, the valuation grade for Max Healthcare Institute Ltd. moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued, with a PE Ratio of 100.29, a Price to Book Value of 12.11, and an EV to EBITDA of 62.71. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Max Healthcare's valuation appears steep, as it has a higher PE ratio than many competitors in the healthcare sector. For instance, while Max Healthcare's PE stands at 100.29, other industry players typically exhibit lower ratios, indicating that investors may be paying a high price for expected growth that may not materialize. Notably, the company's stock has outperformed the Sensex over the past year, with a return of 43% compared to the Sensex's 7.55%, which may have contributed to the inflated valuation.

Has Max Healthcare declared dividend?

Max Healthcare Institute Ltd has declared a 15% dividend, amounting to ₹1.5 per share, with an ex-date of August 23, 2024. The company has shown significant price appreciation over the years, particularly with a total return of 220.75% over three years.

Max Healthcare Institute Ltd has declared a 15% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.13%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 6.09%, with a dividend return of 0%, resulting in a total return of 6.09%.<BR><BR>For the 1-year period, the price return was 40.24%, the dividend return was 0.19%, leading to a total return of 40.43%.<BR><BR>Over the 2-year period, the price return was 122.44%, with a dividend return of 0.42%, culminating in a total return of 122.86%.<BR><BR>In the 3-year period, the price return reached 220.06%, while the dividend return was 0.69%, resulting in a total return of 220.75%.<BR><BR>For the 4-year period, the price return was 373.32%, with a dividend return of 0.98%, leading to a total return of 374.3%.<BR><BR>In the 5-year period, there was no price return or dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, Max Healthcare has declared a dividend, which contributes to its total returns, particularly noticeable over longer periods. The company shows strong price appreciation, especially in the 3 to 4-year periods, despite lower dividend contributions.